These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 21095695

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An automated methodology for levodopa-induced dyskinesia: assessment based on gyroscope and accelerometer signals.
    Tsipouras MG, Tzallas AT, Rigas G, Tsouli S, Fotiadis DI, Konitsiotis S.
    Artif Intell Med; 2012 Jun; 55(2):127-35. PubMed ID: 22484102
    [Abstract] [Full Text] [Related]

  • 3. On automated assessment of Levodopa-induced dyskinesia in Parkinson's disease.
    Tsipouras MG, Tzallas AT, Fotiadis DI, Konitsiotis S.
    Annu Int Conf IEEE Eng Med Biol Soc; 2011 Jun; 2011():2679-82. PubMed ID: 22254893
    [Abstract] [Full Text] [Related]

  • 4. Movement parameters that distinguish between voluntary movements and levodopa-induced dyskinesia in Parkinson's disease.
    Keijsers NL, Horstink MW, Gielen SC.
    Hum Mov Sci; 2003 Feb; 22(1):67-89. PubMed ID: 12623181
    [Abstract] [Full Text] [Related]

  • 5. Long-term monitoring of gait in Parkinson's disease.
    Moore ST, MacDougall HG, Gracies JM, Cohen HS, Ondo WG.
    Gait Posture; 2007 Jul; 26(2):200-7. PubMed ID: 17046261
    [Abstract] [Full Text] [Related]

  • 6. Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features.
    Catalán MJ, Escribano PM, Alonso-Frech F.
    Mov Disord; 2017 Apr; 32(4):624-625. PubMed ID: 28116835
    [No Abstract] [Full Text] [Related]

  • 7. Ambulatory motor assessment in Parkinson's disease.
    Keijsers NL, Horstink MW, Gielen SC.
    Mov Disord; 2006 Jan; 21(1):34-44. PubMed ID: 16127718
    [Abstract] [Full Text] [Related]

  • 8. Detection and assessment of the severity of levodopa-induced dyskinesia in patients with Parkinson's disease by neural networks.
    Keijsers NL, Horstink MW, van Hilten JJ, Hoff JI, Gielen CC.
    Mov Disord; 2000 Nov; 15(6):1104-11. PubMed ID: 11104192
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
    Choudhury S, Pradhan R, Paul P, Das M, Gupta A, Ghosh P, Chatterjee S.
    Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Automated assessment of levodopa-induced dyskinesia: Evaluating the responsiveness of video-based features.
    Li MH, Mestre TA, Fox SH, Taati B.
    Parkinsonism Relat Disord; 2018 Aug; 53():42-45. PubMed ID: 29748112
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease.
    Delamarre A, Tison F, Li Q, Galitzky M, Rascol O, Bezard E, Meissner WG.
    J Neural Transm (Vienna); 2019 Jun; 126(6):789-793. PubMed ID: 31098725
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia.
    Ueno T, Yamada J, Nishijima H, Arai A, Migita K, Baba M, Ueno S, Tomiyama M.
    Neurobiol Dis; 2014 Apr; 64():142-9. PubMed ID: 24398173
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.